Endemic Kaposi's sarcoma in human immunodeficiency virus type 1 seronegative persons: demonstration of retrovirus-like particles in cutaneous lesions
Disease Markers 9(2): 120
1991
ISSN/ISBN: 0278-0240 PMID: 1782744 Document Number: 378404
Document emailed within 1 workday
Related Documents
Warmuth, I.; Moore, P.S. 1997: Kaposi sarcoma, Kaposi sarcoma-associated herpesvirus, and human T-cell lymphotropic virus type 1. what is the current evidence for causality? Archives of Dermatology 133(1): 83-85Okuku, H.Selassie.; Sanders, E.J.; Nyiro, J.; Ngetsa, C.; Ohuma, E.; McClelland, R.Scott.; Price, M.A.; Graham, S.M. 2011: Factors associated with herpes simplex virus type 2 incidence in a cohort of human immunodeficiency virus type 1-seronegative Kenyan men and women reporting high-risk sexual behavior Sexually Transmitted Diseases 38(9): 837-844
Blel, A.; Debbebi, B.; Azouz, H.; Zeddini, A.; Goucha, A.ïd.; Maamouri, F.; Gamoudi, A.; El May, A. 2008: Oropharyngeal Kaposi's sarcoma: about a case not associated to the human immunodeficiency virus La Tunisie Medicale 86(6): 620-621
Lin, C.-Y.; Chen, M.-Y.; Hsieh, S.-M.; Sheng, W.-H.; Sun, H.-Y.; Lo, Y.-C.; Hung, C.-C.; Chang, S.-C. 2009: Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan Journal of Microbiology Immunology and Infection 42(3): 227-233
Hsieh, M-Chun.; Chiu, N-Chang.; Chi, H.; Huang, F-Yuan. 2007: Hepatosplenic Kaposi's sarcoma as the initial presentation in a Taiwanese child with human immunodeficiency virus infection Acta Paediatrica Taiwanica 48(2): 84-88
Olsen, S.J.; Chang, Y.; Moore, P.S.; Biggar, R.J.; Melbye, M. 1998: Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985 Aids 12(14): 1921-1925
Agaoglu, F.Y.; Dizdar, Y.; Basaran, M.; Bilgic, B.; Darendeliler, E. 2004: Human immunodeficiency virus-negative tonsil Kaposi's sarcoma and Hodgkin's disease: case report and review of the literature Journal of BUON: Official Journal of the Balkan Union of Oncology 9(3): 321-324
Sterne, J.A.; Turner, A.C.; Fine, P.E.; Parry, J.V.; Lucas, S.B.; Pönnighaus, J.M.; Mkandwire, P.K.; Nyasulu, S.; Warndorff, D.K. 1995: Testing for antibody to human immunodeficiency virus type 1 in a population in which mycobacterial diseases are endemic Journal of Infectious Diseases 172(2): 543-546
Villarreal García-Lomas, M.; Yebra Bango, M.; García Gasalla, M.; Salas Antón, C. 1998: Nodular cutaneous lesions in a patient with human immunodeficiency virus infection Revista Clinica Espanola 198(7): 469-470
Machado, A.A.; Hirsch, I.; Figueiredo, J.F.; Martinez, R.; de Freitas-Silva, G.; Chermann, J.C.; Covas, D.T. 1996: Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1) Revista da Sociedade Brasileira de Medicina Tropical 29(6): 615-617
Morita, C.; Ikuta, K.; Goto, T.; Sano, K.; Nakai, M.; Hirai, K.; Kato, S. 1990: Isolation and characterization of cell clones persistently producing teardrop-shaped particles of human immunodeficiency virus type 1 Journal of Acquired Immune Deficiency Syndromes 3(3): 231-237
Cannon, M.; Cesarman, E. 2000: Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy Seminars in Oncology 27(4): 409-419
Adamson, S.R. 1998: Experiences of virus, retrovirus and retrovirus-like particles in Chinese hamster ovary (CHO) and hybridoma cells used for production of protein therapeutics Developments in Biological Standardization 93: 89-96
Simonart, T.; Dobbeleer, G.D.; Peny, M.; Fayt, I.; Parent, D.; Vooren, J.; Noel, J. 1999: Pre-Kaposi's sarcoma: an expansion of the spectrum of Kaposi's sarcoma lesions European Journal of Dermatology: Ejd 9(6): 480-482
Caterino-de-Araujo, A.; Magri, M.C.; Manuel, R.C.R. 2010: Patterns of antibodies against latent and lytic antigens of human herpesvirus 8 in an endemic population and patients with Kaposi's sarcoma in Mozambique Journal of Medical Virology 82(9): 1576-1581
Kiwanuka, N.; Laeyendecker, O.; Robb, M.; Kigozi, G.; Arroyo, M.; McCutchan, F.; Eller, L.A.; Eller, M.; Makumbi, F.; Birx, D.; Wabwire-Mangen, F.; Serwadda, D.; Sewankambo, N.K.; Quinn, T.C.; Wawer, M.; Gray, R. 2008: Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection Journal of Infectious Diseases 197(5): 707-713
Balzarini, J.; Velazquez, S.; San-Felix, A.; Karlsson, A.; Perez-Perez, M.J.; Camarasa, M.J.; De Clercq, E. 1993: Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"- oxathiole-2",2"-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues Molecular Pharmacology 43(1): 109-114
Yusim, K.; Peeters, M.; Pybus, O.G.; Bhattacharya, T.; Delaporte, E.; Mulanga, C.; Muldoon, M.; Theiler, J.; Korber, B. 2001: Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 356(1410): 855-866
Bahia; Brites 1999: Human Herpes Virus 8 and Kaposi's Sarcoma: a Review Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 3(5): 166-175
Ambrus, J.L.; Poiesz, B.J.; Lillie, M.A.; Stadler, I.; Di Berardino, L.A.; Chadha, K.C. 1989: Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals American Journal of Medicine 87(4): 405-407